Table 2.

¹⁸F-DCFBC, pathological/clinical and MRI staging results.

Patient	Age	Serum PSA (ng/ml)	Index lesion	MRI staging	18F-DCFBC Staging	Pathologic/clinical staging
1	73	38.64	Gleason 4+5	T3a,Nx,Mx	T3a,N0,M0	T3a,N0,M0
2	67	46.47	Gleason 4+5	T3b,Nx,Mx	T3b,N0,M0	T3b,N1,M0
3	51	4.36	Gleason 4+3	T2a,Nx,Mx	T2a,N0,M0	pT2,pN0,M0
4	53	49.92	Gleason 4+5	T3b,Nx,Mx	T2c,N0,M0	T3b,N0,M0
5	59	9.61	Gleason 3+4	T2b,Nx,Mx	NA	pT3a,pN0,M0
6	66	216.4	Gleason 4+4	T3b,Nx,Mx	T3b,N1,M0	T3b,N1,M0
7	69	47.03	Gleason 4+5	T2c,Nx,Mx	T2a,N0,M0	pT3a,N1,M0
8	55	16.53	Gleason 3+4	T3a,Nx,Mx	NA	T3a,N0,M0
9	66	8.71	Gleason 3+4	T2c,Nx,Mx	T2c,N0,M0	T2c,N0,M0
10	72	26.02	Gleason 4+4	T3a,Nx,Mx	NA	T3a,N0,M0
11	74	3.24	Gleason 3+4	T3a,Nx,Mx	NA	T3a,N0,M0
12	53	3.26	Gleason 4+3 (with ductal features)	NA	NA	pT2,pN0,M0
13	54	10.85	Gleason 4+4	T2c,Nx,Mx	T2a,N0,M0	T2c,N0,M0